APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Enoxaparin Sodium Injection Market Outlook and Growth Opportunities 2026

20 December 2025204 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Injection Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Injection Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Injection Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Enoxaparin Sodium Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Enoxaparin Sodium Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Enoxaparin Sodium Injection market include Teva, Suzhou Erye Pharmaceutical, Sandoz, Sanofi, Nanjing King-friend, Hangzhou Jiuyuan Gene Engineering, Hebei Changshan Biochemical Pharmaceutical, Fresenius Kabi and Changzhou Qianhong Bio-pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enoxaparin Sodium Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enoxaparin Sodium Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enoxaparin Sodium Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enoxaparin Sodium Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Enoxaparin Sodium Injection Segment by Company

Teva

Suzhou Erye Pharmaceutical

Sandoz

Sanofi

Nanjing King-friend

Hangzhou Jiuyuan Gene Engineering

Hebei Changshan Biochemical Pharmaceutical

Fresenius Kabi

Changzhou Qianhong Bio-pharma

Beijing SL Pharmaceutical

Chengdu Baiyu Pharmaceutical

Techdow (Hepalink)

Taj Pharma

Rovi

Cipla

Apotex

Amphastar

Enoxaparin Sodium Injection Segment by Type

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

20 mg/0.2mL

30 mg/0.3mL

300mg/3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

Enoxaparin Sodium Injection Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Enoxaparin Sodium Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Enoxaparin Sodium Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Enoxaparin Sodium Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Enoxaparin Sodium Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enoxaparin Sodium Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Enoxaparin Sodium Injection industry.

Chapter 3: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Enoxaparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Enoxaparin Sodium Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Enoxaparin Sodium Injection Industry Trends Table 2. Enoxaparin Sodium Injection Industry Drivers Table 3. Enoxaparin Sodium Injection Industry Opportunities and Challenges Table 4. Enoxaparin Sodium Injection Industry Restraints Table 5. Global Enoxaparin Sodium Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Enoxaparin Sodium Injection Revenue Share by Company (2021-2026) Table 7. Global Enoxaparin Sodium Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Enoxaparin Sodium Injection Sales Volume Share by Company (2021-2026) Table 9. Global Enoxaparin Sodium Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Enoxaparin Sodium Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Enoxaparin Sodium Injection Key Company Manufacturing Base & Headquarters Table 12. Global Enoxaparin Sodium Injection Company, Product Type & Application Table 13. Global Enoxaparin Sodium Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Enoxaparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100 mg/1mL Table 18. Significant Companies of 120 mg/0.8mL Table 19. Significant Companies of 150 mg/1mL Table 20. Significant Companies of 20 mg/0.2mL Table 21. Significant Companies of 30 mg/0.3mL Table 22. Significant Companies of 300mg/3mL Table 23. Significant Companies of 40 mg/0.4mL Table 24. Significant Companies of 60 mg/0.6mL Table 25. Significant Companies of 80 mg/0.8mL Table 26. Global Enoxaparin Sodium Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Enoxaparin Sodium Injection Sales Volume by Type (2021-2026) & (K Units) Table 28. Global Enoxaparin Sodium Injection Sales Volume by Type (2027-2032) & (K Units) Table 29. Global Enoxaparin Sodium Injection Sales Volume Share by Type (2021-2026) Table 30. Global Enoxaparin Sodium Injection Sales Volume Share by Type (2027-2032) Table 31. Global Enoxaparin Sodium Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Enoxaparin Sodium Injection Sales Value by Type (2021-2026) & (US$ Million) Table 33. Global Enoxaparin Sodium Injection Sales Value by Type (2027-2032) & (US$ Million) Table 34. Global Enoxaparin Sodium Injection Sales Value Share by Type (2021-2026) Table 35. Global Enoxaparin Sodium Injection Sales Value Share by Type (2027-2032) Table 36. Significant Companies of Hospital Table 37. Significant Companies of Clinic Table 38. Significant Companies of Others Table 39. Global Enoxaparin Sodium Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Enoxaparin Sodium Injection Sales Volume by Application (2021-2026) & (K Units) Table 41. Global Enoxaparin Sodium Injection Sales Volume by Application (2027-2032) & (K Units) Table 42. Global Enoxaparin Sodium Injection Sales Volume Share by Application (2021-2026) Table 43. Global Enoxaparin Sodium Injection Sales Volume Share by Application (2027-2032) Table 44. Global Enoxaparin Sodium Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Enoxaparin Sodium Injection Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Enoxaparin Sodium Injection Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Enoxaparin Sodium Injection Sales Value Share by Application (2021-2026) Table 48. Global Enoxaparin Sodium Injection Sales Value Share by Application (2027-2032) Table 49. Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Enoxaparin Sodium Injection Sales by Region (2021-2026) & (K Units) Table 51. Global Enoxaparin Sodium Injection Sales Market Share by Region (2021-2026) Table 52. Global Enoxaparin Sodium Injection Sales by Region (2027-2032) & (K Units) Table 53. Global Enoxaparin Sodium Injection Sales Market Share by Region (2027-2032) Table 54. Global Enoxaparin Sodium Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Enoxaparin Sodium Injection Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Enoxaparin Sodium Injection Sales Value Share by Region (2021-2026) Table 57. Global Enoxaparin Sodium Injection Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Enoxaparin Sodium Injection Sales Value Share by Region (2027-2032) Table 59. Global Enoxaparin Sodium Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Enoxaparin Sodium Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Global Enoxaparin Sodium Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 64. Global Enoxaparin Sodium Injection Sales Market Share by Country (2021-2026) Table 65. Global Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 66. Global Enoxaparin Sodium Injection Sales Market Share by Country (2027-2032) Table 67. Global Enoxaparin Sodium Injection Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Enoxaparin Sodium Injection Sales Value Market Share by Country (2021-2026) Table 69. Global Enoxaparin Sodium Injection Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Enoxaparin Sodium Injection Sales Value Market Share by Country (2027-2032) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Enoxaparin Sodium Injection Product Portfolio Table 75. Teva Recent Development Table 76. Suzhou Erye Pharmaceutical Company Information Table 77. Suzhou Erye Pharmaceutical Business Overview Table 78. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 80. Suzhou Erye Pharmaceutical Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sandoz Enoxaparin Sodium Injection Product Portfolio Table 85. Sandoz Recent Development Table 86. Sanofi Company Information Table 87. Sanofi Business Overview Table 88. Sanofi Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sanofi Enoxaparin Sodium Injection Product Portfolio Table 90. Sanofi Recent Development Table 91. Nanjing King-friend Company Information Table 92. Nanjing King-friend Business Overview Table 93. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio Table 95. Nanjing King-friend Recent Development Table 96. Hangzhou Jiuyuan Gene Engineering Company Information Table 97. Hangzhou Jiuyuan Gene Engineering Business Overview Table 98. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio Table 100. Hangzhou Jiuyuan Gene Engineering Recent Development Table 101. Hebei Changshan Biochemical Pharmaceutical Company Information Table 102. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 103. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 105. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 106. Fresenius Kabi Company Information Table 107. Fresenius Kabi Business Overview Table 108. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio Table 110. Fresenius Kabi Recent Development Table 111. Changzhou Qianhong Bio-pharma Company Information Table 112. Changzhou Qianhong Bio-pharma Business Overview Table 113. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio Table 115. Changzhou Qianhong Bio-pharma Recent Development Table 116. Beijing SL Pharmaceutical Company Information Table 117. Beijing SL Pharmaceutical Business Overview Table 118. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 120. Beijing SL Pharmaceutical Recent Development Table 121. Chengdu Baiyu Pharmaceutical Company Information Table 122. Chengdu Baiyu Pharmaceutical Business Overview Table 123. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 125. Chengdu Baiyu Pharmaceutical Recent Development Table 126. Techdow (Hepalink) Company Information Table 127. Techdow (Hepalink) Business Overview Table 128. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio Table 130. Techdow (Hepalink) Recent Development Table 131. Taj Pharma Company Information Table 132. Taj Pharma Business Overview Table 133. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Taj Pharma Enoxaparin Sodium Injection Product Portfolio Table 135. Taj Pharma Recent Development Table 136. Rovi Company Information Table 137. Rovi Business Overview Table 138. Rovi Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Rovi Enoxaparin Sodium Injection Product Portfolio Table 140. Rovi Recent Development Table 141. Cipla Company Information Table 142. Cipla Business Overview Table 143. Cipla Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Cipla Enoxaparin Sodium Injection Product Portfolio Table 145. Cipla Recent Development Table 146. Apotex Company Information Table 147. Apotex Business Overview Table 148. Apotex Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Apotex Enoxaparin Sodium Injection Product Portfolio Table 150. Apotex Recent Development Table 151. Amphastar Company Information Table 152. Amphastar Business Overview Table 153. Amphastar Enoxaparin Sodium Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Amphastar Enoxaparin Sodium Injection Product Portfolio Table 155. Amphastar Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Enoxaparin Sodium Injection Distributors List Table 159. Enoxaparin Sodium Injection Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Injection Product Image Figure 2. Global Enoxaparin Sodium Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Enoxaparin Sodium Injection Sales (2021-2032) & (K Units) Figure 5. Global Enoxaparin Sodium Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Enoxaparin Sodium Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100 mg/1mL Image Figure 10. 120 mg/0.8mL Image Figure 11. 150 mg/1mL Image Figure 12. 20 mg/0.2mL Image Figure 13. 30 mg/0.3mL Image Figure 14. 300mg/3mL Image Figure 15. 40 mg/0.4mL Image Figure 16. 60 mg/0.6mL Image Figure 17. 80 mg/0.8mL Image Figure 18. Global Enoxaparin Sodium Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Enoxaparin Sodium Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 20. Global Enoxaparin Sodium Injection Sales Volume Share by Type (2021-2032) Figure 21. Global Enoxaparin Sodium Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Enoxaparin Sodium Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Enoxaparin Sodium Injection Sales Value Share by Type (2021-2032) Figure 24. Hospital Image Figure 25. Clinic Image Figure 26. Others Image Figure 27. Global Enoxaparin Sodium Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Enoxaparin Sodium Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Enoxaparin Sodium Injection Sales Volume Share by Application (2021-2032) Figure 30. Global Enoxaparin Sodium Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Enoxaparin Sodium Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Enoxaparin Sodium Injection Sales Value Share by Application (2021-2032) Figure 33. Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Enoxaparin Sodium Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Enoxaparin Sodium Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Enoxaparin Sodium Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Enoxaparin Sodium Injection Sales Value (2021-2032) & (US$ Million) Figure 38. North America Enoxaparin Sodium Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Enoxaparin Sodium Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Enoxaparin Sodium Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Enoxaparin Sodium Injection Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Enoxaparin Sodium Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Enoxaparin Sodium Injection Sales Value (2021-2032) & (US$ Million) Figure 44. South America Enoxaparin Sodium Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Enoxaparin Sodium Injection Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Enoxaparin Sodium Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Enoxaparin Sodium Injection Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Enoxaparin Sodium Injection Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 300mg/3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Suzhou Erye Pharmaceutical
  • Sandoz
  • Sanofi
  • Nanjing King-friend
  • Hangzhou Jiuyuan Gene Engineering
  • Hebei Changshan Biochemical Pharmaceutical
  • Fresenius Kabi
  • Changzhou Qianhong Bio-pharma
  • Beijing SL Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Techdow (Hepalink)
  • Taj Pharma
  • Rovi
  • Cipla
  • Apotex
  • Amphastar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enoxaparin Sodium Injection Sales Value (2021-2032)
  4. 1.2.2 Global Enoxaparin Sodium Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Enoxaparin Sodium Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Enoxaparin Sodium Injection Market Dynamics
  1. 2.1 Enoxaparin Sodium Injection Industry Trends
  2. 2.2 Enoxaparin Sodium Injection Industry Drivers
  3. 2.3 Enoxaparin Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Injection Industry Restraints
3 Enoxaparin Sodium Injection Market by Company
  1. 3.1 Global Enoxaparin Sodium Injection Company Revenue Ranking in 2025
  2. 3.2 Global Enoxaparin Sodium Injection Revenue by Company (2021-2026)
  3. 3.3 Global Enoxaparin Sodium Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Enoxaparin Sodium Injection Average Price by Company (2021-2026)
  5. 3.5 Global Enoxaparin Sodium Injection Company Ranking (2024-2026)
  6. 3.6 Global Enoxaparin Sodium Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Enoxaparin Sodium Injection Company Product Type and Application
  8. 3.8 Global Enoxaparin Sodium Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Enoxaparin Sodium Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Enoxaparin Sodium Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Enoxaparin Sodium Injection Market by Type
  1. 4.1 Enoxaparin Sodium Injection Type Introduction
  2. 4.1.1 100 mg/1mL
  3. 4.1.2 120 mg/0.8mL
  4. 4.1.3 150 mg/1mL
  5. 4.1.4 20 mg/0.2mL
  6. 4.1.5 30 mg/0.3mL
  7. 4.1.6 300mg/3mL
  8. 4.1.7 40 mg/0.4mL
  9. 4.1.8 60 mg/0.6mL
  10. 4.1.9 80 mg/0.8mL
  11. 4.2 Global Enoxaparin Sodium Injection Sales Volume by Type
  12. 4.2.1 Global Enoxaparin Sodium Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Enoxaparin Sodium Injection Sales Volume by Type (2021-2032)
  14. 4.2.3 Global Enoxaparin Sodium Injection Sales Volume Share by Type (2021-2032)
  15. 4.3 Global Enoxaparin Sodium Injection Sales Value by Type
  16. 4.3.1 Global Enoxaparin Sodium Injection Sales Value by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Enoxaparin Sodium Injection Sales Value by Type (2021-2032)
  18. 4.3.3 Global Enoxaparin Sodium Injection Sales Value Share by Type (2021-2032)
5 Enoxaparin Sodium Injection Market by Application
  1. 5.1 Enoxaparin Sodium Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Enoxaparin Sodium Injection Sales Volume by Application
  6. 5.2.1 Global Enoxaparin Sodium Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enoxaparin Sodium Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Enoxaparin Sodium Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Enoxaparin Sodium Injection Sales Value by Application
  10. 5.3.1 Global Enoxaparin Sodium Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Enoxaparin Sodium Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Enoxaparin Sodium Injection Sales Value Share by Application (2021-2032)
6 Enoxaparin Sodium Injection Regional Sales and Value Analysis
  1. 6.1 Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enoxaparin Sodium Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Enoxaparin Sodium Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Enoxaparin Sodium Injection Sales by Region (2027-2032)
  5. 6.3 Global Enoxaparin Sodium Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Enoxaparin Sodium Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Enoxaparin Sodium Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Enoxaparin Sodium Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Enoxaparin Sodium Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Enoxaparin Sodium Injection Sales Value (2021-2032)
  12. 6.6.2 North America Enoxaparin Sodium Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Enoxaparin Sodium Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Enoxaparin Sodium Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Enoxaparin Sodium Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Enoxaparin Sodium Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Enoxaparin Sodium Injection Sales Value (2021-2032)
  21. 6.9.2 South America Enoxaparin Sodium Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Enoxaparin Sodium Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Enoxaparin Sodium Injection Sales Value Share by Country, 2025 VS 2032
7 Enoxaparin Sodium Injection Country-level Sales and Value Analysis
  1. 7.1 Global Enoxaparin Sodium Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Enoxaparin Sodium Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Enoxaparin Sodium Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Enoxaparin Sodium Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Enoxaparin Sodium Injection Sales by Country (2027-2032)
  6. 7.4 Global Enoxaparin Sodium Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Enoxaparin Sodium Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Enoxaparin Sodium Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Enoxaparin Sodium Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Enoxaparin Sodium Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Enoxaparin Sodium Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Enoxaparin Sodium Injection Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Suzhou Erye Pharmaceutical
  8. 8.2.1 Suzhou Erye Pharmaceutical Company Information
  9. 8.2.2 Suzhou Erye Pharmaceutical Business Overview
  10. 8.2.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  12. 8.2.5 Suzhou Erye Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Enoxaparin Sodium Injection Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Enoxaparin Sodium Injection Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Nanjing King-friend
  26. 8.5.1 Nanjing King-friend Company Information
  27. 8.5.2 Nanjing King-friend Business Overview
  28. 8.5.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio
  30. 8.5.5 Nanjing King-friend Recent Developments
  31. 8.6 Hangzhou Jiuyuan Gene Engineering
  32. 8.6.1 Hangzhou Jiuyuan Gene Engineering Company Information
  33. 8.6.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  34. 8.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio
  36. 8.6.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  37. 8.7 Hebei Changshan Biochemical Pharmaceutical
  38. 8.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  39. 8.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  40. 8.7.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  42. 8.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Changzhou Qianhong Bio-pharma
  50. 8.9.1 Changzhou Qianhong Bio-pharma Company Information
  51. 8.9.2 Changzhou Qianhong Bio-pharma Business Overview
  52. 8.9.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio
  54. 8.9.5 Changzhou Qianhong Bio-pharma Recent Developments
  55. 8.10 Beijing SL Pharmaceutical
  56. 8.10.1 Beijing SL Pharmaceutical Company Information
  57. 8.10.2 Beijing SL Pharmaceutical Business Overview
  58. 8.10.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  60. 8.10.5 Beijing SL Pharmaceutical Recent Developments
  61. 8.11 Chengdu Baiyu Pharmaceutical
  62. 8.11.1 Chengdu Baiyu Pharmaceutical Company Information
  63. 8.11.2 Chengdu Baiyu Pharmaceutical Business Overview
  64. 8.11.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  66. 8.11.5 Chengdu Baiyu Pharmaceutical Recent Developments
  67. 8.12 Techdow (Hepalink)
  68. 8.12.1 Techdow (Hepalink) Company Information
  69. 8.12.2 Techdow (Hepalink) Business Overview
  70. 8.12.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio
  72. 8.12.5 Techdow (Hepalink) Recent Developments
  73. 8.13 Taj Pharma
  74. 8.13.1 Taj Pharma Company Information
  75. 8.13.2 Taj Pharma Business Overview
  76. 8.13.3 Taj Pharma Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Taj Pharma Enoxaparin Sodium Injection Product Portfolio
  78. 8.13.5 Taj Pharma Recent Developments
  79. 8.14 Rovi
  80. 8.14.1 Rovi Company Information
  81. 8.14.2 Rovi Business Overview
  82. 8.14.3 Rovi Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Rovi Enoxaparin Sodium Injection Product Portfolio
  84. 8.14.5 Rovi Recent Developments
  85. 8.15 Cipla
  86. 8.15.1 Cipla Company Information
  87. 8.15.2 Cipla Business Overview
  88. 8.15.3 Cipla Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Cipla Enoxaparin Sodium Injection Product Portfolio
  90. 8.15.5 Cipla Recent Developments
  91. 8.16 Apotex
  92. 8.16.1 Apotex Company Information
  93. 8.16.2 Apotex Business Overview
  94. 8.16.3 Apotex Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Apotex Enoxaparin Sodium Injection Product Portfolio
  96. 8.16.5 Apotex Recent Developments
  97. 8.17 Amphastar
  98. 8.17.1 Amphastar Company Information
  99. 8.17.2 Amphastar Business Overview
  100. 8.17.3 Amphastar Enoxaparin Sodium Injection Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Amphastar Enoxaparin Sodium Injection Product Portfolio
  102. 8.17.5 Amphastar Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enoxaparin Sodium Injection Value Chain Analysis
  2. 9.1.1 Enoxaparin Sodium Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enoxaparin Sodium Injection Sales Mode & Process
  6. 9.2 Enoxaparin Sodium Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enoxaparin Sodium Injection Distributors
  9. 9.2.3 Enoxaparin Sodium Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst